Country: Tajwan
Lingwa: Ċiniż
Sors: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)
TIPRANAVIR
台灣百靈佳殷格翰股份有限公司 台北市中山區民生東路三段2號12樓 (12469866)
J05AE09
軟膠囊劑
TIPRANAVIR (0818003200) MG
塑膠瓶裝
製 劑
須由醫師處方使用
WEST-WARD COLUMBUS INC. 1809, Wilson Road, Columbus, OH 43228, USA US
tipranavir
Aptivus與低劑量ritonavir合用,適用於曾經接受三種主要類別的抗病毒藥物充分治療(highly treatment-experienced)失敗,或對多種蛋白酶抑制劑產生抗藥性之愛滋病毒感染的成人。
註銷日期: 2020/11/06; 註銷理由: 自請註銷; 有效日期: 2021/10/30; 英文品名: Aptivus Capsules 250mg
已註銷
2006-10-30
Excipients polyoxyl castor oil, ethanol 100% (w/w), mono/diglycerides of caprylic/capric acid, propylene glycol, purified water, trometamol, propyl gallate Capsule shell: gelatin, ferric oxide red, propylene glycol, purified water, sorbitol special glycerine blend A810, and titanium dioxide Black printing ink: SDA 35 alcohol, propylene glycol, ferric oxide black, polyvinyl acetate phthalate, purified water, isopropyl alcohol, macrogol/PEG 400 and ammonia hydroxide 28% Autoimmune disorders (such as Graves' disease, polymyositis, and Guillain-Barré syndrome) have also been reported to occur in the setting of immune reconstitution; however, the time to onset is more variable, and can occur many months after initiation of treatment. 20100906+HA request dated on 20120727 賦形劑:polyoxyl castor oil, ethanol 100% (w/w), mono/diglycerides of caprylic/capric acid, propylene glycol, purified water, trometamol, propyl gallate 膠囊殼: gelatin, ferric oxide red, propylene glycol, purified water, sorbitol special glycerine blend A810, and titanium dioxide Black printing ink: SDA 35 alcohol, propylene glycol, ferric oxide black, polyvinyl acetate phthalate, purified water, isopropyl alcohol, macrogol/PEG 400 and ammonia hydroxide 28% 曾有報告顯示,使用該藥品可能發生自體免疫異常之 狀況(例如Grave's disease, polymyositis, Guillain-Barre syndrome) ,其發生時間不確定,可能於開始治療數個 月後。 20100906 + HA request dated on 20120727 PDE-5抑制劑: Tadalafil:APTIVUS與低劑量ritonavir合用,同時又投與 狀態,若有臨床需要則可增加tadalafil的劑量。 tadalafil ,於APTIVUS/ritonavir的首次劑量時會導致 tadalafil濃度增加2.3倍,但在APTIVUS/ritonavir穩定濃 度狀態時則無變化。如果tadalafil在APTIVUS/ritonavir 療法的第一天就併用,則應投與最低劑量。然而經過7- 10天的給藥後,tipranavir與ritonavir皆達到穩定濃度 Aqra d-dokument sħiħ